BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26754863)

  • 1. Nicotinamide found to reduce the rate of nonmelanoma skin cancers in high-risk patients.
    Barton MK
    CA Cancer J Clin; 2016; 66(2):91-2. PubMed ID: 26754863
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment.
    Hajdenberg J
    Ann Intern Med; 2016 Feb; 164(4):JC18. PubMed ID: 26882303
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicotinamide for Skin-Cancer Chemoprevention.
    Drago F; Ciccarese G; Parodi A
    N Engl J Med; 2016 Feb; 374(8):789-90. PubMed ID: 26933858
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinamide for Skin-Cancer Chemoprevention.
    Zhao Y
    N Engl J Med; 2016 Feb; 374(8):789. PubMed ID: 26933857
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Damian DL
    N Engl J Med; 2016 Feb; 374(8):790. PubMed ID: 26933856
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin cancer: Nicotinamide reduces new skin cancer risk.
    Sidaway P
    Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26525684
    [No Abstract]   [Full Text] [Related]  

  • 7. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
    N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?
    Nestor L; Clowry J; Molloy K; Connolly M; Salim A; Tobin AM
    Clin Exp Dermatol; 2017 Dec; 42(8):945-946. PubMed ID: 29044731
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicotinamide for skin cancer chemoprevention.
    Damian DL
    Australas J Dermatol; 2017 Aug; 58(3):174-180. PubMed ID: 28321860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
    Arzeno J; Leavitt E; Lonowski S; Kim J
    Dermatol Surg; 2021 Jul; 47(7):995-997. PubMed ID: 33587370
    [No Abstract]   [Full Text] [Related]  

  • 11. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?
    Minocha R; Damian DL; Halliday GM
    Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):5-12. PubMed ID: 28681504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide: New Indications in Dermatology.
    Escudero-Góngora MM; Fernández-Peñas P
    Actas Dermosifiliogr; 2016 Nov; 107(9):777-778. PubMed ID: 27377936
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials.
    Surjana D; Halliday GM; Martin AJ; Moloney FJ; Damian DL
    J Invest Dermatol; 2012 May; 132(5):1497-500. PubMed ID: 22297641
    [No Abstract]   [Full Text] [Related]  

  • 14. Nicotinamide and skin cancer chemoprevention: The jury is still out.
    Gilmore SJ
    Australas J Dermatol; 2018 Feb; 59(1):6-9. PubMed ID: 29192960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclo-oxygenase-2 inhibitors for chemoprevention of nonmelanoma skin cancer: is there a role for these agents?
    Liebman TN; Stein JA; Polsky D
    J Am Acad Dermatol; 2013 Jan; 68(1):173-6. PubMed ID: 23244374
    [No Abstract]   [Full Text] [Related]  

  • 16. Periocular actinic keratosis, keratinocyte carcinomas, and eyeglasses use.
    Lee KC; Weinstock MA;
    J Am Acad Dermatol; 2013 Jul; 69(1):165-7. PubMed ID: 23768294
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study.
    Drago F; Ciccarese G; Cogorno L; Calvi C; Marsano LA; Parodi A
    Eur J Dermatol; 2017 Aug; 27(4):382-385. PubMed ID: 28468736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
    Nemer KM; Council ML
    Dermatol Clin; 2019 Jul; 37(3):287-295. PubMed ID: 31084723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
    Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
    N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
    Tee LY; Sultana R; Tam SYC; Oh CC
    J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.